Talis Biomedical Corporation Revenue per Employee (TLIS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Talis Biomedical Corporation  (NASDAQ: TLIS)
 

Talis Biomedical's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Talis Biomedical's Revenue per employee grew on a trailing twelve month basis to $ 6,375, below the company average.
Within the Healthcare sector Talis Biomedical Corporation achieved the highest revenue per employee. While revenue/employee total ranking has improved so far to , from total ranking in previous quarter at 3917. Talis Biomedical has 64 employees.


What is Sales per Employee Ratio?







TLIS Revenue per Employee (Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
Y / Y Revenue Change - -94.01 % -24.12 % -82.41 % 1.57 %
Sales per Employee (TTM) $ 6,375 15,453 33,344 34,313 44,563
TLIS's Total Ranking # # 3917 # 4094 # 3940 # 3937
Seq. Revenue Change - -62.56 % 39.29 % -75.9 % -52.3 %


Revenue per Employee Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 128,016 $ 64,839 $ 15,453
(Dec 31 2021)   (Mar 31 2024)



Financial Statements
Talis Biomedical's Revenue MRQ $ 0 Millions Visit TLIS's Income Statement
Talis Biomedical's Revenues TTM $ 0 Millions Visit TLIS's aggregate revenue growth
What are TLIS's Sales? Visit TLIS's Sales by Segment




Other Ratios
Talis Biomedical's Income per Employee
Employees in Laboratory Analytical Instruments
Laboratory Analytical Instruments Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
TLIS's Revenue per Employee versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for TLIS's Competitors
Revenue per Employee for TLIS's Suppliers
Revenue per Employee for TLIS's Customers

You may also want to know
TLIS's Sales Growth Rates TLIS's Pe Price to earnings ratio TLIS's Receivables Turnover Ratio TLIS's Stock Quote
TLIS's Net Income Growth Rates TLIS's Ps Price to Sales ratio TLIS's Sales per Employee TLIS's Asset Turnover Ratio
TLIS's Net Margin TLIS's Pb Price to Book ratio TLIS's Financial Strength Ratios TLIS's Dividend Payout Ratio
Date modified: 2026-08-29T17:43:13+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2024, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2024Number of Employees Jun 30 2024
Praxis Precision Medicines Inc   10,541.67 $ 1.771  Million 168 
Skinvisible Inc   10,000.00 $ 0.020  Million
Aim Immunotech Inc   9,571.43 $ 0.201  Million 21 
Serina Therapeutics Inc   8,812.50 $ 0.141  Million 16 
Orgenesis Inc   8,597.40 $ 0.662  Million 77 
Altimmune inc   7,175.44 $ 0.409  Million 57 
Streamex Corp   6,666.67 $ 0.040  Million
Arch Therapeutics Inc   6,173.42 $ 0.148  Million 24 
Pluri Inc   6,037.04 $ 0.326  Million 54 
Clene Inc   5,594.94 $ 0.442  Million 79 
Scpharmaceuticals Inc   5,496.69 $ 24.048  Million 4,375 
Geron Corporation  5,321.71 $ 1.373  Million 258 
Aclarion Inc   4,904.27 $ 0.054  Million 11 
Abvc Biopharma Inc   4,839.31 $ 0.140  Million 29 
Cytokinetics Incorporated  4,656.76 $ 3.134  Million 673 
Bio Green Med Solution Inc   4,210.53 $ 0.080  Million 19 
Hyperion Defi inc   3,489.44 $ 0.031  Million




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.